The Prevalence of Doping in Flanders in Comparison to the Prevalence of Doping in International Sports

International Journal of Sports Medicine

Volumn 24, Issue 8, 2003, Pages 565-570

  Van Eenoo, P ^a   Delbeke, F T ^a  

^a GHENT UNIVERSITY   (Belgium)

Author keywords

Analysis; Cannabis; Drug use; Flanders; IOC; Statistics

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BOLDENONE; CANNABIS; CENTRAL STIMULANT AGENT; DIURETIC AGENT; DROSTANOLONE; ILLICIT DRUG; MESTEROLONE; METANDIENONE; METENOLONE; METHYLTESTOSTERONE; NANDROLONE; NARCOTIC AGENT; PEPTIDE HORMONE; STANOZOLOL; TESTOSTERONE;

ARTICLE; ATHLETE; BELGIUM; BODY BUILDING; COMPARATIVE STUDY; CONTROLLED STUDY; DATA ANALYSIS; DOPING; DRUG DETERMINATION; FEMALE; HEALTH PROGRAM; HUMAN; INCIDENCE; INTERNATIONAL COOPERATION; LABORATORY; MALE; PREVALENCE; SAMPLE; SEX RATIO; SPORT; STATISTICAL ANALYSIS; WEIGHT LIFTING;

BELGIUM; DOPING IN SPORTS; FEMALE; HUMANS; INCIDENCE; INTERNATIONALITY; MALE; PREVALENCE; SEX DISTRIBUTION;

EID: 0242408812     PISSN: 01724622     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2003-43269     Document Type: Article

References (20)

1. Bahr R, Tjornhom M. Prevalence of doping in sports: doping control in Norway, 1977-1995. Clin J Sport Med 1998; 8: 32-37
2. Benzi G. Pharmacoepidemiology of the drugs used in sports as doping agents. Pharmacol Res 1994; 29: 13-26
3. Bidlingmaier M, Wu Z, Strasburger CJ. Doping with growth hormone. J Pediatr Endocr Met 2001; 14: 1077-1084
4. De Cock KJS, Delbeke FT, Van Eenoo P, Desmet N, Roels K, De Backer P. Detection and determination of anabolic steroids in nutritional supplements. J Pharm Biomed Anal 2001; 25: 843-852
5. Decree of the Flemish Executive. C-2000/36128 of 31 October 2000 (B S. 25.11.2000)
6. Delbeke FT. Doping in cyclism: results of unannounced controls in Flanders (1987-1994). Int J Sports Med 1996; 17: 434-438
7. Delbeke FT, Debackere M. The influence of diuretics on the excretion and metabolism of doping agents. 1-Mephentermine. J Pharm Biomed Anal 1985; 3: 141-148
8. Delbeke FT, Desmet N, Debackere M. The abuse of doping agents in competing body builders in Flanders (1988-1993). Int J Sports Med 1995; 16: 66-70
9. Donike M, Bärwald KR, Klostermann K, Schänzer W, Zimmermann J. Nachweis von exogenem Testosterone (Detection of exogenous testosterone). In: Heck H., Hollmann W., Liesen H. (eds). Sport: Leistung und Gesundheit. Kongressbd. Dtsch Sportärztekongress. Köln, Deutscher Ärzte Verlag 1983: 293-298
10. Lasne F, de Ceaurriz J. Recombinant erythropoietin in urine. Nature 2000; 405: 635
11. International Olympic Committee. List of Prohibited Classes of Substances and Prohibited Methods Lausanne: 2001
12. Melia P, Pipe A, Greenberg L. The use of anabolic-androgenic steroids by Canadian students. Clin J Sport Med 1996; 6: 9-14
13. Mottram DR, George AD. Anabolic Steroids. Best Pract Res Cl En 2000; 14: 55-69
14. Parisotto R, Gore C, Emslie K, Ashenden M, Brugnara C, Howe C, Martin D, Trout G, Hahn A. A novel method utilizing markers of altered erythropoiesis for the detection of recombinant erythropoietin abuse in athletes. Haematologica 2000; 85: 564-572
15. Scarpino V, Arrigo A, Benzi G, Arattini S, Lavecchia C, Bernardi LR, Silvestrini G, Tuccimei G. Evaluation of prevalence of "doping" among Italian athletes. Lancet 1990; 336: 1048-1050
16. van der Merwe PJ, Kruger HSL. Drugs in sport - results of the past 6 years of dope testing in South Africa. S Afr Med J 1992; 82: 151-153
17. van Eenoo P, Delbeke FT, Roels K, De Backer P. Simultaneous quantitation of ephedrines in urine by gas chromatography-nitrogen-phosphorus detection for doping control purposes. J Chromatogr B 2001; 760: 255-261
18. Wu Z, Bidlingmaier M, Dall R, Strasburger CJ. Detection of doping with human growth hormone. Lancet 1999; 353: 895
19. Yesalis CE, Bahrke MS. Doping among adolescent athletes. Best Pract Res Cl En 2000; 14: 25-35
20. Yesalis CE. Anabolic Steroids in Sport and Exercise. Champaign (Il):Humanetics Kinetics Publisher 1993: 325